|
|
|
Volumn 58, Issue 139, 1993, Pages 39406-39416
|
|
Guideline for the study and evaluation of gender differences in the clinical evaluation of drugs; notice.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG;
NEW DRUG;
PSYCHOTROPIC AGENT;
AGE;
ARTICLE;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
FEMALE;
FEMALES;
FOOD AND DRUG ADMINISTRATION;
GENERAL ACCOUNTING OFFICE;
GOVERNMENT;
GOVERNMENT REGULATION;
HEALTH;
HUMAN EXPERIMENT;
LEGAL APPROACH;
MALE;
METHODOLOGY;
PATIENT SELECTION;
POLICY;
PRACTICE GUIDELINE;
PREGNANCY;
SELECTION OF SUBJECTS;
SOCIAL CONTROL;
UNITED STATES;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
FEDERAL GOVERNMENT;
FEMALES;
FOOD AND DRUG ADMINISTRATION;
GENERAL ACCOUNTING OFFICE;
GOVERNMENT REGULATION;
LEGAL APPROACH;
MALES;
PREGNANT WOMEN;
RESEARCH SUBJECTS;
SELECTION OF SUBJECTS;
UNITED STATES;
AGE FACTORS;
DRUGS, INVESTIGATIONAL;
GOVERNMENT;
GUIDELINES;
HUMAN EXPERIMENTATION;
MEN;
PATIENT SELECTION;
PHARMACEUTICAL PREPARATIONS;
PREGNANCY;
PSYCHOTROPIC DRUGS;
PUBLIC POLICY;
RESEARCH DESIGN;
SOCIAL CONTROL, FORMAL;
STATISTICS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
WOMEN;
WOMEN'S HEALTH;
|
|
EID: 0027922323
PISSN: 00976326
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (199)
|
|
References (0)
|